ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy (FARN)

195,00
-15,00
(-7,14%)
Fermé 21 Janvier 5:30PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
195,00
Prix Achat
190,00
Prix Vente
200,00
Volume échangé
30 519
195,00 Fourchette du Jour 210,00
89,00 Plage de 52 semaines 306,00
Cap du marché
Clôture Veille
210,00
Ouverture
210,00
Dernière Transaction
866
@
190.05
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
16 598
Actions en circulation
104 620 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,59
Bénéfice par action (BPA)
-0,3
Chiffre d'affairess
-
Bénéfice net
-30,94M

À propos de Faron Pharmaceuticals Oy

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Turku, Fin
Fondé
-
Faron Pharmaceuticals Oy est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker FARN. Le dernier cours de clôture d'Faron Pharmaceuticals Oy était de 210,00p. Au cours de la dernière année, les actions de Faron Pharmaceuticals Oy ont été négociées dans une fourchette de prix de 89,00p à 306,00p.

Faron Pharmaceuticals Oy compte actuellement 104 620 000 actions en circulation. La capitalisation boursière d'Faron Pharmaceuticals Oy est de £219,70 million. Faron Pharmaceuticals Oy a un ratio cours/bénéfice (ratio PE) de -6.59.

FARN Dernières nouvelles

Faron Pharmaceuticals Oy Faron’s Financial Calendar for 2025

Faron Pharmaceuticals Oy 13 December 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Faron's Financial Calendar for 2025   Company announcement, 13 December 2024 TURKU...

IN BRIEF: Faron Pharmaceuticals shares up as presents data on Bexmab

cals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive ph ...

Faron presents BEXMAB data at ASH Annual Meeting

Faron presents BEXMAB data at ASH Annual Meeting PR Newswire TURKU, Finland, Dec. 10, 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2...

Faron announces promising findings from blood cancer drug trial

Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...

Faron Pharmaceuticals Oy Positive Phase 2 Interim Results from BEXMAB Trial

Faron Pharmaceuticals Oy 27 November 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...

Faron Pharmaceuticals Oy Shareholders’ Nomination Board

Faron Pharmaceuticals Oy 05 November 2024   ("Faron" or "the Company")    Composition of Faron Pharmaceutical's Shareholders' Nomination Board   Company Announcement, 5 November 2024   TURKU...

Faron Pharmaceuticals Oy Faron’s Capital Markets Day 2024

Faron Pharmaceuticals Oy 22 October 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")    Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...

Faron Pharmaceuticals Oy Grant of options

Faron Pharmaceuticals Oy 30 August 2024   Faron Pharmaceuticals Ltd.   ("Faron" or "the Company")   Grant of options   Company announcement, August 30, 2024   TURKU, FINLAND - Faron...

Faron Pharma shares surge as US FDA grants fast track designation

Faron Pharmaceuticals Ltd on Tuesday said its loss widened in the first half of 2024, as the company successfully adv ...

Faron Pharmaceuticals Oy Faron 2024 Half-Year Financial Results

Faron Pharmaceuticals Oy 27 August 2024   Faron Pharmaceuticals Ltd. ("Faron" or "the Company")   Faron Reports Half-Year Financial Results, 1 January - 30 June 2024     Company Announcement...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-5-2.520021519512092207.52051736DE
43018.181818181816521516510319203.93297591DE
12158.33333333333180215142.516598175.49641584DE
266246.616541353413323313324048181.0551922DE
52-95-32.75862068972903068939777150.10642226DE
156-68.5-25.9962049336263.5392.58921219194.11844702DE
260-65-252605608931473293.58289426DE

FARN - Frequently Asked Questions (FAQ)

What is the current Faron Pharmaceuticals Oy share price?
The current share price of Faron Pharmaceuticals Oy is 195,00p
How many Faron Pharmaceuticals Oy shares are in issue?
Faron Pharmaceuticals Oy has 104 620 000 shares in issue
What is the market cap of Faron Pharmaceuticals Oy?
The market capitalisation of Faron Pharmaceuticals Oy is GBP 219,7M
What is the 1 year trading range for Faron Pharmaceuticals Oy share price?
Faron Pharmaceuticals Oy has traded in the range of 89,00p to 306,00p during the past year
What is the PE ratio of Faron Pharmaceuticals Oy?
The price to earnings ratio of Faron Pharmaceuticals Oy is -6,59
What is the reporting currency for Faron Pharmaceuticals Oy?
Faron Pharmaceuticals Oy reports financial results in EUR
What is the latest annual profit for Faron Pharmaceuticals Oy?
The latest annual profit of Faron Pharmaceuticals Oy is EUR -30,94M
What is the registered address of Faron Pharmaceuticals Oy?
The registered address for Faron Pharmaceuticals Oy is JOUKAHAISENKATU 6, INTELLIGATE, TURKU, FIN-20520
What is the Faron Pharmaceuticals Oy website address?
The website address for Faron Pharmaceuticals Oy is www.faronpharmaceuticals.com
Which industry sector does Faron Pharmaceuticals Oy operate in?
Faron Pharmaceuticals Oy operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
WSLWorldsec Ld
2,00p
(60,00%)
105,37k
BLUBlue Star Capital Plc
12,00p
(45,45%)
1,54M
NTQEnteq Technologies Plc
1,40p
(40,00%)
19,81M
BANKFiinu Plc
10,25p
(36,67%)
12,95M
TIRTiger Royalties And Investments Plc
0,16p
(28,00%)
139,07M
PODPPod Point Group Holdings Plc
10,88p
(-35,20%)
6,83M
PALMPanther Metals Plc
53,50p
(-35,15%)
226,06k
NOGNostrum Oil & Gas Plc
2,51p
(-23,82%)
117,6k
ADMEAdm Energy Plc
0,175p
(-22,22%)
1,19M
PRDPredator Oil & Gas Holdings Plc
5,85p
(-20,95%)
5,72M
NTVONativo Resources Plc
0,0021p
(10,53%)
844,9M
TRPTower Resources Plc
0,0305p
(-1,61%)
507,22M
PREMPremier African Minerals Limited
0,027p
(-3,57%)
504,81M
SYMESupply@me Capital Plc
0,003p
(-13,04%)
461,39M
ORCPOracle Power Plc
0,016p
(-5,88%)
308,68M
Aucune Discussion Trouvée
Ajouter une Discussion